Moloney Securities Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.47M | Sell |
5,854
-203
| -3% | -$151K | 0.53% | 42 |
|
|
2025
Q2 | $4.72M | Sell |
6,057
-820
| -12% | -$637K | 0.58% | 32 |
|
|
2025
Q1 | $5.68M | Buy |
6,877
+388
| +6% | +$323K | 0.77% | 23 |
|
|
2024
Q4 | $5.01M | Sell |
6,489
-51
| -0.8% | -$42.2K | 0.67% | 36 |
|
|
2024
Q3 | $5.79M | Buy |
6,540
+1,178
| +22% | +$1.06M | 0.78% | 27 |
|
|
2024
Q2 | $4.86M | Buy |
5,362
+78
| +1% | +$62.4K | 0.7% | 32 |
|
|
2024
Q1 | $4.11M | Buy |
5,284
+91
| +2% | +$64.8K | 0.62% | 39 |
|
|
2023
Q4 | $3.03M | Sell |
5,193
-40
| -0.8% | -$23.3K | 0.48% | 53 |
|
|
2023
Q3 | $2.81M | Sell |
5,233
-38
| -0.7% | -$19.6K | 0.51% | 50 |
|
|
2023
Q2 | $2.47M | Buy |
5,271
+1
| +0% | +$419 | 0.44% | 59 |
|
|
2023
Q1 | $1.81M | Buy |
5,270
+402
| +8% | +$136K | 0.34% | 74 |
|
|
2022
Q4 | $1.78M | Sell |
4,868
-132
| -3% | -$46.8K | 0.39% | 74 |
|
|
2022
Q3 | $1.62M | Buy |
5,000
+28
| +0.6% | +$8.87K | 0.39% | 66 |
|
|
2022
Q2 | $1.61M | Sell |
4,972
-80
| -2% | -$24K | 0.38% | 75 |
|
|
2022
Q1 | $1.45M | Buy |
5,052
+323
| +7% | +$83.1K | 0.28% | 101 |
|
|
2021
Q4 | $1.31M | Sell |
4,729
-12,773
| -73% | -$3.24M | 0.22% | 112 |
|
|
2021
Q3 | $4.04M | Buy |
17,502
+13,391
| +326% | +$3.31M | 0.74% | 32 |
|
|
2021
Q2 | $944K | Sell |
4,111
-124
| -3% | -$24.9K | 0.17% | 154 |
|
|
2021
Q1 | $791K | Buy |
4,235
+96
| +2% | +$18.8K | 0.16% | 156 |
|
|
2020
Q4 | $699K | Sell |
4,139
-3,741
| -47% | -$559K | 0.16% | 160 |
|
|
2020
Q3 | $1.17M | Buy |
7,880
+1,122
| +17% | +$174K | 0.31% | 90 |
|
|
2020
Q2 | $1.11M | Buy |
6,758
+228
| +3% | +$35K | 0.32% | 92 |
|
|
2020
Q1 | $906K | Buy |
6,530
+2,144
| +49% | +$295K | 0.32% | 96 |
|
|
2019
Q4 | $576K | Sell |
4,386
-220
| -5% | -$25.5K | 0.18% | 149 |
|
|
2019
Q3 | $515K | Buy |
4,606
+62
| +1% | +$6.9K | 0.17% | 149 |
|
|
2019
Q2 | $503K | Buy |
4,544
+564
| +14% | +$66.4K | 0.17% | 151 |
|
|
2019
Q1 | $516K | Buy |
3,980
+109
| +3% | +$13.3K | 0.18% | 150 |
|
|
2018
Q4 | $448K | Buy |
3,871
+1,582
| +69% | +$177K | 0.18% | 150 |
|
|
2018
Q3 | $246K | Sell |
2,289
-194
| -8% | -$19.4K | 0.09% | 239 |
|
|
2018
Q2 | $212K | Buy |
+2,483
| New | +$204K | 0.08% | 260 |
|
|
2018
Q1 | – | Sell |
-2,452
| Closed | -$207K | – | 306 |
|
|
2017
Q4 | $207K | Buy |
2,452
+1
| +0% | +$85 | 0.09% | 236 |
|
|
2017
Q3 | $210K | Buy |
2,451
+1
| +0% | +$82 | 0.09% | 243 |
|
|
2017
Q2 | $202K | Buy |
2,450
+49
| +2% | +$4K | 0.1% | 228 |
|
|
2017
Q1 | $202K | Buy |
+2,401
| New | +$192K | 0.1% | 219 |
|
Other funds holding LLY
Moloney Securities Asset Management's LLY Position: Q3 2025 in Review
Moloney Securities Asset Management reduced its Eli Lilly (LLY) stake by 3.4% in Q3 2025, selling an estimated $151K and leaving 5,854 shares worth $4.47M. The position accounts for 0.53% of the portfolio, ranked #42.
Moloney Securities Asset Management first reported a position in LLY in Q1 2017 and has held it in 34 quarters since. The position peaked at $5.79M in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Moloney Securities Asset Management held 5,854 shares of Eli Lilly worth $4.47M as of Q3 2025.
- Moloney Securities Asset Management sold 203 Eli Lilly shares in Q3 2025, an estimated $151K.
- Eli Lilly made up 0.53% of Moloney Securities Asset Management's portfolio in Q3 2025, its #42 holding.
- Moloney Securities Asset Management first reported a position in Eli Lilly in Q1 2017 and has held it in 34 quarters since.
- Moloney Securities Asset Management's Eli Lilly position peaked at $5.79M in Q3 2024.
- 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.